Outcomes following adjuvant treatment (AT) for colon cancer (CC) 1978-1995 versus 1996-2007: Impact on recurrence rate, time from recurrence to death (TRD), and overall survival (OS) -- Findings from the ACCENT dataset. Andre, T. , Shi, Q. , Yothers, G. , Bot, B. , Haller, D. ... - ASCO - J. Clin. Oncol. - 2010 Abstract - Secondary - Primary - GI - NCCTG-N0441
Innovative estimation of survival using log-normal survival modelling on ACCENT database Chapman, J W , O'Callaghan, C J , Hu, N , Ding, K , Yothers, G A ... - - Br. J. Cancer - 2013 Manuscript - No-Endpoint - Primary - GI - N0441
Comparison of innovative estimation of efficacy to standard using the ACCENT database. Chapman, J. W. , O'Callaghan, C. , Hu, N. , Ding, K. , Yothers, G. A. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary - Primary - GI - NCCTG-N0441
The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database Cheung, Winson Y. , Shi, Qian , O'Connell, Michael , Cassidy, James ... - - Clin Colorectal Cancer - 2013 Manuscript - Secondary - Primary - GI - N0441
Body mass index (BMI) and DNA mismatch repair status in colon cancers from patients treated in adjuvant therapy trials. Foster, N. R. , Sinicrope, F. , Yothers, G. , Allegra, C. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary - Primary - GI - N994C
Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index Gresham, Gillian , Diniz, Márcio A , Razaee, Zahra S , Luu, Michael ... - - J Natl Cancer Inst - 2020 Manuscript - Secondary-not-in-original - Primary - - NSABP R-04
Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set Hubbard, Joleen , Thomas, David M. , Yothers, Greg , Green, Erin ... - - J. Clin. Oncol - 2012 Manuscript - Secondary - Comprehensive - GI - ACCENT , CALGB-89803
Analysis of time-dependent patterns of treatment effect and failure to explain the predictive role of deficient mismatch repair (dMMR) in stage II and III colon cancer (CC) Kim, G. P. , Marsoni, S. , Monges, G. , Allegra, C. J. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary - Primary - GI - N994C
Time-dependent patterns of treatment effect and failure as an explanation for the predictive role of deficient mismatch repair (dMMR) in colon cancer. Kim, G. , Marsoni, S. , Monges, G. , Allegra, C. , Thibodeau, S. N. ... - ASCO GI - Gastrointestinal Cancers Symposium - 2010 Abstract - Secondary - Primary - GI - NCCTG-N994C
Genetic predictors of severe skin toxicity in stage III colon cancer patients treated with cetuximab: NCCTG N0147 (Alliance) Labadie, Julia D. , Hua, Xinwei , Harrison, Tabitha A. ... - - Cancer Epidemiol Biomarkers Prev - 2021 Manuscript - Secondary-not-in-original - Primary - PPP - N0147
Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database McCleary, Nadine J. , Meyerhardt, Jeffrey A. , Green, Erin ... - - J. Clin. Oncol - 2013 Manuscript - Secondary - Primary - GI - NCCTG-N0441
Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database Mccleary, N. A. J. , Meyerhardt, J. , Green, E. , Yothers, G. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - GI - NCCTG-N0441
Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database Papamichael, Demetris , Renfro, Lindsay A. , Matthaiou, Christiana ... - - J Geriatr Oncol - 2016 Manuscript - Secondary - Primary - GI - ACCENT
Genetic Variant Associated with Survival of Patients with Stage II-III Colon Cancer Penney, Kathryn L. , Banbury, Barbara L. , Bien, Stephanie ... - - Clin. Gastroenterol. Hepatol. - 2019 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147
Genome-wide association with survival in stage II-III colon cancer (CC) clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology) Penney, Kathryn , Banbury, Barbara L. , Shi, Qian ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original - Primary - PPP - N0147
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. Romond, Edward H , Perez, Edith A , Bryant, John , Suman, Vera J ... - - N. Engl. J. Med. - 2005 Manuscript - Secondary-not-in-original - Primary - Breast - N9831
Use of two-year disease-free survival (DFS) as a primary endpoint in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: New data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, NSAPB C-06 and C-07, and C89803. Sargent, D. J. , Yothers, G. , Van Cutsem, E. , Cassidy, J. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original - Meta-Analysis - GI - CALGB-89803
Benefits and adverse events in younger (age<50) vs. older patients receiving adjuvant chemotherapy for colon cancer: Findings From the 33,574 pt ACCENT dataset. Sargent, D. , Yothers, G. , Green, E. , Blanke, C. , O'Connell, M. ... - - J. Clin. Oncol. - 2010 Abstract - Secondary - Primary - GI - N0441
Two or Three Year Disease Free Survival (DFS) as a Primary Endpoint in Stage III Adjuvant Colon Cancer Trials with fluoropyrimidines with or without Oxaliplatin or Irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07, and C89803 Sargent, D , Shi, Q , Yothers, G , Van Cutsem, E , Cassidy, J ... - - Eur J Cancer - 2011 Manuscript - Secondary-not-in-original - Comprehensive - GI - C89803
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. Sargent, Daniel J , Patiyil, Smitha , Yothers, Greg ... - - J. Clin. Oncol. - 2007 Manuscript - No-Endpoint - Other - GI - ACCENT
Lymph node (LN) ratio (LNR) risk classification (RC) in stage III colon cancer (CC): A pooled analysis of 16,425 patients from the ACCENT database. Shi, Q. , Hubbard, J. M. , Yothers, G. A. , Andre, T. , Saltz, L. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N0441
Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database Shi, Qian , Andre, Thierry , Grothey, Axel , Yothers, Greg ... - - J. Clin. Oncol. - 2013 Manuscript - Secondary-not-in-original - Meta-Analysis - GI - CALGB-89803 , NCCTG-784852 , NCCTG-874651 , NCCTG-894651 , NCCTG-914653
Body mass index (BMI) as a prognostic and predictive factor in stage II/III colon cancer: An analysis of the ACCENT database Sinicrope, F. , Foster, N. , Yothers, G. , Benson, A. , Haller, D. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary - Primary - GI - NCCTG-N0441
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy Sinicrope, Frank A. , Foster, Nathan R. , Thibodeau, Stephen N. ... - - J Natl Cancer Inst - 2011 Manuscript - Secondary - Primary - GI - N994C
Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials Sinicrope, Frank A. , Foster, Nathan R. , Yoon, Harry H. ... - - J Clin Oncol - 2012 Manuscript - Secondary-not-in-original - Comprehensive - GI - N994C
Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy Sinicrope, Frank A. , Foster, Nathan R. , Yothers, Greg , Benson, Al ... - - Cancer - 2013 Manuscript - Secondary-not-in-original - Meta-Analysis - GI - N0441 , NCCTG-78-48-52 , NCCTG-87-46-51 , NCCTG-89-46-51 , NCCTG-91-46-53 , NCCTG-N0441
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS with Survival after Recurrence in Stage III Colon Cancers from Phase III Adjuvant Chemotherapy Trials Sinicrope, Frank A. , Shi, Qian , Allegra, Carmen J. ... - - JAMA Oncol - 2017 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147
Molecular markers and survival after recurrence in stage III colon cancers from NCCTG N0147 and NSABP C-08 adjuvant chemotherapy trials Sinicrope, Frank A. , Shi, Qian , Allegra, Carmen Joseph ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - N0147
Outcomes in white (W) patients (pts) and those of African (A) descent receiving adjuvant therapy for colon cancer (CC) Yothers, G. , Blackstock, A. W. , Wolmark, N. , Goldberg, R. M. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original - Meta-Analysis - GI - C89803 , NCCTG-N0441
Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials Yothers, Greg , Sargent, Daniel J. , Wolmark, Norman ... - - J Natl Cancer Inst - 2011 Manuscript - Secondary - Primary - GI - N0441
Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set de Gramont, Aimery , Hubbard, Joleen , Shi, Qian ... - - J Clin Oncol - 2010 Manuscript - Secondary - Primary - GI - N9741
